<DOC>
	<DOCNO>NCT02145000</DOCNO>
	<brief_summary>The study double-blinded , randomize , placebo-controlled , trial two group infant receive vaccine placebo ass efficacy safety BRV-PV . Three dose BRV-PV contain â‰¥ Log10 5.6 FFU/Dose serotype G1 , G2 , G3 , G4 G9 administer 4 week interval dos . The first administration occur 6-8 week age . We hypothesize difference vaccine efficacy three dose BRV-PV vaccine vs. placebo severe rotavirus gastroenteritis healthy infant Niger . Active surveillance gastroenteritis episode conduct throughout trial . Surveillance adverse event carry among child time first vaccination 28 day post-Dose 3 . Surveillance serious adverse event , include intussusception death , conduct participant reach two year age . To assess effect prenatal nutrition supplementation infant immune response BRV-PV vaccine , study village immunogenicity sub-cohort randomized 1:1:1 ratio provide pregnant woman daily iron-folate , multiple micronutrient lipid-based nutrition supplement . Infants participate woman , eligible 6-8 week age , randomize 1:1 ratio receive three dos vaccine placebo enter main trial part immunogenicity sub-cohort .</brief_summary>
	<brief_title>Efficacy Safety Pentavalent Rotavirus Vaccine ( BRV-PV ) Against Severe Rotavirus Gastroenteritis Niger</brief_title>
	<detailed_description />
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1. age 68 week time inclusion 2. able swallow history vomit within 24 hour 3. resident Madarounfa Health District within catchment area central health facility 4. intend remain study area 2 year 5. parent/guardian provide write informed consent Any follow exclude infant randomization study : 1. known history congenital abdominal disorder , intussusception , abdominal surgery 2. receipt intramuscular , oral , intravenous corticosteroid treatment within 2 wks 3. receipt plan administration blood transfusion blood product , include immunoglobulin 4. know immunodeficiency condition 5. serious medical condition 6. condition , judgment investigator , would interfere serf contraindication protocol adherence parent/guardian 's ability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Rotavirus</keyword>
	<keyword>Gastroenteritis</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Niger</keyword>
</DOC>